Ira J. Bleiweiss, MD
Pathology and Laboratory Medicine
Headshot of Ira J. Bleiweiss, MD

Ira J. Bleiweiss, MD

Pathology and Laboratory Medicine
Sees patients age 18 and up
Penn Pathology and Laboratory Medicine HUP
Headshot of Ira J. Bleiweiss, MD
Penn Medicine Provider

About me

  • Professor of Pathology and Laboratory Medicine at the Hospital of the University of Pennsylvania

My education and training

  • Saint George's University School of MedicineMedical School
  • Mount Sinai Medical CenterResidency
  • Mount Sinai Medical CenterFellowship
  • Memorial Sloan-Kettering Cancer CenterFellowship

Spoken languages

English
English

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
Dr. Bleiweiss is a Penn Medicine provider.

Qualifications and experience

All conditions and treatments

Research

Publications

Zafar U, Duque PNA, Vickey J, Bleiweiss IJ, Nayak A. Benign and atypical breast vascular lesions in the era of expanded breast MRI: radiologic-pathologic correlation and downstream surgical outcomes. Abstract accepted for presentation at the United States and Canadian Academy Pathologists Annual Meeting, Vancouver, March 2027. , Modern Pathology: 2027


Avalos Hernandez S, Hu T, Vickery J, Dumoff K, Bleiweiss I, Nayak A Clinicopathologic Spectrum of Cystic Hypersecretory Breast Lesions and Ki-67 Index Analysis , Modern Pathology: 2026


Tondi Resta I, Nelson ND, Toorens E, Bleiweiss IJ, Nayak A Mucinous Cystadenocarcinomas of the Breast Exhibit Heterogeneous Genomic Profile as Triple Negative Breast Cancer, Harbor Alterations in PIK3CA, PTEN, AKT1, and GNAS Genes, and May Not Be Indolent , Int J Surg Pathol, 33(7): 2025,1583-1592


Nayak A, Demarest K, Bleiweiss IJ, Shah PD Pathologic response of metaplastic carcinomas to KEYNOTE-522 regimen: correlation with histological subtypes. , Mod Pathol: 2025


Avalos Hernandez SR, Hu T, Dumoff KL, Vickery JM Bleiweiss IJ, Nayak A Invasive lobular carcinoma with extracellular mucin (ILCEM) presenting at distant metastases and recurrences may exhibit triple negative phenotype , Mod Pathol: 2025


Tondi Resta I, Hu T, Dumoff KL, Avalos Hernandez SR, Vickery JM Bleiweiss IJ, Nayak A Tubulopapillary carcinomas of the breast: histopathologic features, immunohistochemical staining with p16, p53, and SOX10, and molecular findings , Mod Pathol: 2025


Narasimhamurthy M, Le A, Boruah N, Moses R, Kelly G, Bleiweiss I, Maxwell KN, Nayak A. Clinicopathologic Features of Breast Tumors in Germline TP53 Variant-Associated Li-Fraumeni Syndrome , Am J Surg Pathol, 49: 2025,195-205


Tondi Resta I, Goldbach MM, Tchou JC, Bleiweiss IJ, Nayak A Pathologic Features and Residual Cancer Burden (RCB) after Neoadjuvant Endocrine Therapy (NET) in Hormone Receptor Positive Breast Cancer (HR+ BC). , Mod Pathol: 2024


Lennerz JK, Pantanowitz L, Amin MB, et al. Ensuring remote diagnostics for pathologists: an open letter to the US Congress. , Nat Med, 12: 2022,2453-2455


Narasimhamurthy M, Good M, Desai H, Le A, Bleiweiss IJ, Maxwell K, Nayak A Clinico-pathological features of breast tumors associated with Li-Fraumeni Syndrome , Mod Pathology, 35: 2022,196-198